The trademark Nova Aura was filed by ZytoVision GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on April 23, 2023, and received undefined oppositions.
Opposition Proceedings
There are undefined Oppositions claimed against trademark.
The first opposition filed on July 23, 2023 by Merz Pharma GmbH & Co. KGaA on Likelihood of confusion. the opponent was represented by BALDER IP LAW, S.L. and its proceedings were handled in German The second opposition filed on July 23, 2023 by Carl Zeiss AG on Likelihood of confusion. the opponent was represented by ELZABURU, S.L.P. and its proceedings were handled in English The third opposition filed on July 18, 2023 by AMBU A/S on Likelihood of confusion. the opponent was represented by BECH-BRUUN LAW FIRM and its proceedings were handled in English
The application was filed in German, and German was also language of all opposition proceedings (English was selected as the second language).
Relative errors of the trademark registration was recorded on December 21, 2023.
Goods And Services
The mark was filed in class 1 with following description of goods:
Chemicals for use in industry and science
Chemicals, Biochemicals, for use in the following fields: pathology, Genetics, Human genetics, molecular pathologies, Molecular biology, Microbiology, Biotechnology, Laboratory medicine
Chemicals and biochemicals for histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, PCR (polymerase chain reaction), NGS (next generation sequencing), microarray hybridisation (genetic chip or biochip hybridisation), flow cytometry services and isolation of biomolecules including DNA, RNA and proteins
Nucleic acids (including DNA, RNA, oligonucleotides, polynucleotides, marked nucleic acids and modified nucleic acids), proteins (including peptides, recombinant proteins and marked proteins), antibodies, DNA probes being biochemical substances, RNA probes being biochemical substances, oligonucleotide probes being biochemical substances, cells, tissue, tissue sections, and nucleic acids, proteins and cells immobilised on carriers
None of the goods included in this class being for use in connection with artificial respiration.
The mark was filed in class 5 with following description of goods:
Pharmaceuticals and medical preparations
Medical preparations for diagnostics
Medical preparations for in-vitro diagnostics
Pharmaceuticals, Pharmaceutical preparations, medical products, Medical preparations, Chemical products, chemical preparations, Biochemical products, Biochemical preparations, For medical purposes, for use in the following fields: pathology, Genetics, Human genetics, molecular pathologies, Molecular biology, Microbiology, biotechnology, laboratory medicine
Pharmaceutical, medicated, chemical and biochemicals and preparations for medical purposes for histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, PCR (polymerase chain reaction), NGS (next generation sequencing), microarray hybridisation (genetic chip or biochip hybridisation), flow cytometry services and isolation of biomolecules including DNA, RNA and proteins
Nucleic acids (including DNA, RNA, oligonucleotides, polynucleotides, marked nucleic acids and modified nucleic acids), proteins (including peptides, recombinant proteins and marked proteins), antibodies, DNA probes being biochemical substances, RNA probes being biochemical substances, oligonucleotide probes being biochemical substances, cells, tissue, tissue sections, and nucleic acids, proteins and cells immobilised on carriers
None of the goods included in this class being for use in connection with artificial respiration
None of the goods included in this class being for use in connection with medical preparations for treating Alzheimer's disease
None of the goods included in this class being for use in connection with medical preparations for treating diseases in the neurological field.
The mark was filed in class 9 with Analysers for conducting immunohistology, immunohistochemistry, in situ hybridisation and none of the goods in this class for use in connection with artificial respiration..
The mark was filed in class 10 with following description of goods:
Medical apparatus and instruments, excluding the following goods: Respiratory apparatus and Ventilation instruments, Masks, Laryngeal masks, Artificial respiratory devices, apparatus for respiratory management
Medical instruments, excluding the following goods: Ventilation instruments, Masks, Laryngeal masks, Artificial respiratory devices, apparatus for respiratory management
Medical analytical apparatus for medical purposes
Automatic analyzers for medical diagnosis
Physical analyzers for medical use
Genetic testing apparatus for medical purposes
None of the goods included in this class being for use in connection with artificial respiration.